We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Robotic System Makes Coronary Stenting Easier

By HospiMedica International staff writers
Posted on 04 Jun 2012
A remote controlled robotic system can safely and effectively guide implantation of stents during percutaneous coronary intervention (PCI) procedures, according to a new study.

Researchers at Columbia University Medical Center (New York, NY, USA), enrolled 164 patients (mean age 64, 75% male) at nine sites to the CorPath Percutaneous Robotically-Enhance Coronary Intervention Study (PRECISE) study. More...
Most of the patients had hypertension, hyperlipidemia, and a prior PCI. Lesions had to be 24 mm or less in length, able to be covered by one stent with 2 mm margins, and with a reference vessel diameter of 2.5-4 mm. The primary endpoint was clinical procedural success, defined as less than 30% residual stenosis in the target lesion at the completion of the procedure, and the absence of major adverse cardiac events (MACE) at 48 hours post index procedure or at hospital discharge, whichever occurs first.

The results showed that technical success, defined as completing a procedure without the need to convert to manual operation, was successfully completed in 98.8% of patients, without device-related complications. There were no in-hospital deaths, Q-wave myocardial infarcts (MIs), or revascularizations; however, there were four non-Q-wave MIs. At 30 days, there were no additional major adverse events. The mean robotic procedure duration was 24 minutes, mean fluoroscopy duration was 11 minutes, and the mean contrast volume used was 144 mL. The study was presented at the Society for Cardiovascular Angiography and Interventions meeting, held during May 2012 in Las Vegas (NV, USA).

“Of the 162 procedures, physicians needed to convert to manual implantation in only two instances, and the fault was not that of the robotic system,” said lead author Giora Weisz, MD. “The remote interventional cockpit also reduced operator radiation exposure by 95%.”

The CorPath 200 robotic device, a product of Corindus Vascular Robotics (Natick, MA, USA), provides procedure control for PCI procedures from an interventional cockpit, allowing precise, robotic-assisted placement of coronary guidewires and stents or balloon catheters. The physician operates in a comfortable environment, completely focused on patient physiology. The ergonomically optimized cockpit enhances visualization, minimizes fatigue, and protects the operator against exposure to radiation and other occupational hazards such as back strain from heavy lead protection aprons.

Related Links:

Columbia University Medical Center
Corindus Vascular Robotics



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Critical Care Conversion Kit
Adapter+
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.